首页> 外文期刊>Intensive care medicine >Low seroprevalence of Helicobacter pylori infection in patients with stress ulcer bleeding--a prospective evaluation of patients on a cardiosurgical intensive care unit.
【24h】

Low seroprevalence of Helicobacter pylori infection in patients with stress ulcer bleeding--a prospective evaluation of patients on a cardiosurgical intensive care unit.

机译:应激性溃疡出血患者的幽门螺杆菌感染低血清阳性率-对心脏外科重症监护室患者的前瞻性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The pathogenesis of stress ulceration in seriously ill patients is uncertain and the pathogenic role of Helicobacter pylori infection is unknown. We therefore assessed the seroprevalence of patients of a cardiosurgical intensive care unit (ICU) with clinically important stress ulcer bleeding. We compared this prevalence with a control group matched for this kind of surgical intervention, missing history of peptic ulcer disease, age and gender. DESIGN: Prospective survey. SETTING: Cardiosurgical ICU in a university teaching hospital. Patients and participants: Two thousand five hundred seventy cardiosurgical patients with intravenous ranitidine stress ulcer prophylaxis were screened for clinically important stress ulcer bleeding. Helicobacter pylori seropositivity was measured in all patients with a clinically important bleeding and in a control group of 245 consecutive cardiosurgical patients, matched for the kind of cardiosurgical intervention, age and gender. RESULTS: In 56 of 2,570 (2.1%) patients signs of clinically important bleeding were seen. Endoscopical examination revealed stress ulcer bleeding in 42 cases. The incidence of stress ulcer bleeding was 1.6%. The seropositivity of the group with ulcer bleeding was 45.2 % whereas 62.4 % of the patients in the control group were Helicobacter pylori positive (p = 0.08). CONCLUSIONS: Our results suggest that the Helicobacter pylori infection does not play a pathogenic role in stress ulcer bleeding. Prophylactic cure of Helicobacter pylori can not be recommended in this setting.
机译:目的:重症患者应激性溃疡的发病机制尚不确定,幽门螺杆菌感染的致病作用尚不清楚。因此,我们评估了具有临床重要应激性溃疡出血的心脏外科重症监护病房(ICU)患者的血清阳性率。我们将这种患病率与对照组进行了比较,该对照组适合进行这种外科手术,缺少消化性溃疡病史,年龄和性别。设计:前瞻性调查。地点:大学教学医院的心脏外科ICU。患者和参与者:筛选了257例雷诺替丁静脉预防性静脉曲张的心脏外科手术患者,以寻找具有临床意义的应激性溃疡出血。在所有具有重要临床意义的出血的患者中以及在245名连续的心脏外科手术患者的对照组中,测量了幽门螺杆菌的血清阳性,这与心脏外科手术的种类,年龄和性别相匹配。结果:在2570名患者中有56名(2.1%)出现了具有临床意义的重要出血迹象。内镜检查发现应激性溃疡出血42例。应激性溃疡出血的发生率为1.6%。溃疡出血组的血清阳性率为45.2%,而对照组的62.4%的患者为幽门螺杆菌阳性(p = 0.08)。结论:我们的研究结果表明幽门螺杆菌感染在应激性溃疡出血中没有致病作用。在这种情况下,不建议对幽门螺杆菌进行预防性治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号